Screener / SEC EDGAR /CIK 0001280263 /10-K filed Mar 23, 2026, compared with Mar 28, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Technology · Semiconductors

Ambarella Inc AMBA

Compare with peers Embed
Earnings releases

Latest results release: Sep 3, 2026

8-K item 2.02, exhibit 99

What AMBA's management wrote with each quarter's results: the press release and, when the company files them, its prepared remarks or the call transcript. The call itself is not filed with SEC, so most quarters have the release only.

Adjusted vs GAAP earnings per share

In the company's own words · read from each release, never computed

What the company says its adjusted numbers leave out:

A reconciliation of the GAAP to non-GAAP gross margin, net income (loss) and earnings (losses) per share for the periods presented, as well as a description of the items excluded from the non-GAAP calculations, is included in the financial statements portion of this press release. release Sep 3, 2026

Both numbers are read from the words of each release (usually the highlights), never computed by us; hover a number for its sentence. Quarters where the release gives them only in a table are not shown. The company decides what "adjusted" leaves out; the full reconciliation is in the release.

Read and search

Every release, in full · linked to sec.gov

Press release Sep 3, 2026 · EX-99.1

Exhibit 99.1 Ambarella, Inc. Announces Second Quarter Fiscal Year 2027 Financial

Open on SEC

Exhibit 99.1 Ambarella, Inc. Announces Second Quarter Fiscal Year 2027 Financial Results September 3, 2026 —Santa Clara, Calif. – Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company, today announced second quarter fiscal 2027 financial results for the period ended July 31, 2026.

Revenue for the second quarter of fiscal 2027 was $108.1 million, up 13.2% from $95.5 million in the • same period in fiscal 2026. For the six months ended July 31, 2026, revenue was $208.5 million, up 14.9% from $181.4 million for the six months ended July 31, 2025.

Gross margin under U.S. generally accepted accounting principles (GAAP) for the second quarter of fiscal 2027 was 57.7%, compared with 58.9% for the same period in fiscal 2026. For the six months ended July 31, 2026, GAAP gross margin was 58.0%, compared • with 59.4% for the six months ended July 31, 2025. ──────────────────────────────────────────────────────────────────────────────

GAAP net loss for the second quarter of fiscal 2027 was $6.7 million, or loss per diluted ordinary share of $0.15, compared with a GAAP net loss of $20.0 million, or loss per diluted ordinary share of $0.47, for the same period in fiscal 2026. • GAAP net loss for the six months ended July 31, 2026 was $24.8 million or loss per diluted ordinary share of $0.57. This compares with GAAP net loss of $44.3 million, or loss per diluted ordinary share of $1.05, for the six months ended July 31, 2025.

Financial results on a non-GAAPbasis for the second quarter of fiscal 2027 are as follows:

Non-GAAP net income for the second quarter of fiscal 2027 was $8.2 million, or earnings per diluted ordinary share of $0.18. This compares with non-GAAP net income of $6.4 million, or earnings per diluted ordinary share of $0.15, for the same period in fiscal • 2026. Non-GAAP net income for the six months ended July 31, 2026 was $13.3 million, or earnings per diluted ordinary share of $0.30. This compares with non-GAAP net income of $9.5 million, or earnings per diluted ordinary share of $0.22, for the six months ended July 31, 2025.

Based on information available as of today, Ambarella is offering the following guidance for the third quarter of fiscal year 2027, ending October 31, 2026:

• Non-GAAP operating expenses are expected to be between $56.5 million and $59.5 million.

Ambarella reports gross margin, net income (loss) and earnings (losses) per share in accordance with GAAP and, additionally, on a non-GAAP basis. Non-GAAP financial information excludes the impact of stock-based compensation and acquisition-related costs adjusted for the associated tax impact, which includes the effect of any benefits or shortfalls recognized. In addition, in our second quarter of fiscal 2027, we recognized a one-time $9.0 million reduction in our GAAP research and development expense on release of a deposit liability following the termination of a development project. Given the nature of this credit and that it is non-recurring, we excluded it from operating expenses for the purpose of reporting non-GAAP financial results. A reconciliation of the GAAP to non-GAAP gross margin, net income (loss) and earnings (losses) per share for the periods presented, as well as a description of the items excluded from the non-GAAP calculations, is included in the financial statements portion of this press release.

Total cash, cash equivalents and marketable debt securities on hand at the end of the second quarter of fiscal 2027 was $272.3 million, compared with $277.8 million at the end of the prior quarter and $261.2 million at the end of the same quarter a year ago.

“Our edge AI revenue reached record levels in Q2, with balanced sequential growth in Auto and IoT markets with very strong growth from our 5nm CV75 and CV72 AI SoCs. We are making significant progress with our strategic priorities to extend our market reach with new higher value products and the implementation of new go-to-market strategies. These include the introduction of our first stand-alone AI Accelerator, X7, and the execution of 7-year agreements to develop the indirect sales channel with both Macnica, a leading global technical distributor, and CapGemini, a leading global engineering and systems integration firm,” said Fermi Wang, President & CEO. “These developments are contributing to an increase in our 5-year serviceable market (“SAM”) forecast for edge AI and Physical AI.”

Ambarella plans to hold a conference call at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time today with Fermi Wang, President and Chief Executive Officer, and John Young, Chief Financial Officer, to discuss the second quarter of fiscal year 2027 results. A live and archived webcast of the call will be available on Ambarella’s website at for up to 30 days after the call.

With an installed base of more than 50 million AI SoC units, Ambarella’s products are utilized in a wide variety of physical edge AI applications, spanning edge endpoint and edge infrastructure use cases including physical security, vehicle safety, telematics, autonomy, portable video, aerial drones, and other emerging robotic applications. Building on this footprint, Ambarella offers a full-stack edge AI platform, from highly optimized silicon and programmable software to AI agentic frameworks that coordinate perception, decision-making and control across devices. Ambarella’s low-power systems-on- chip (SoCs) integrate proprietary and highly efficient perception and deep learning neural network AI accelerators, enabling electronic systems to become more productive with partial or complete levels of machine autonomy. For more information, please visit

“Safe harbor” statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements that are not historical facts and often can be identified by terms such as “outlook,” “projected,” “intends,” “will,” “estimates,” “anticipates,” “expects,” “believes,” “could,” “should,” or similar expressions, including the guidance for the third quarter of fiscal year 2027 ending October 31, 2026, and the comments of our CEO relating to demand for edge AI solutions, our progress with strategic priorities to extend our market reach, our ability to successfully build an indirect sales channel, the forecasted size of our serviceable market (“SAM”), and our ability to successfully penetrate the edge AI and Physical AI markets. The achievement or success of the matters covered by such forward-looking statements involves risks, uncertainties and assumptions. Our actual results could differ materially from those predicted or implied and reported results should not be considered as an indication of our future performance.

The risks and uncertainties referred to above include, but are not limited to, global economic and political conditions; changes in government policies, including possible trade tariffs and restrictions; revenue being generated from new customers or design wins, neither of which is assured; the commercial success of our customers’ products; our customers’ ability to manage their inventory requirements; our growth strategy; our ability to anticipate future market demands and future needs of our customers, particularly for AI inference applications; our ability to introduce, and to generate revenue from, new and enhanced solutions; our ability to develop, and to generate revenue from, new advanced technologies, such as AI functionality and advanced networks, including vision- language models and GenAI; our ability to retain and expand customer relationships and to achieve design wins; the expansion of our current markets and our ability to successfully enter new markets and applications, such as edge infrastructure; anticipated trends and challenges, including competition, in the markets in which we operate; risks associated with global health conditions and associated risk mitigation measures; our ability to effectively manage growth; our ability to retain key employees; and the potential for intellectual property disputes or other litigation.

Further information on these and other factors that could affect our financial results is included in the company’s Annual Report on Form 10-K for our 2026 fiscal year, which is on file with the Securities and Exchange Commission. Additional information will also be set forth in the company’s quarterly reports on Form 10-Q, annual reports on Form 10-K and other filings the company makes with the Securities and Exchange Commission from time to time, copies of which may be obtained by visiting the Investor Relations portion of our web site at or the SEC’s web site at www.sec.gov. Undue reliance should not be placed on the forward-looking statements in this release, which are based on information available to us on the date hereof. The results we report in our Quarterly Report on Form 10-Q for the second quarter of fiscal 2027 ended July 31, 2026 could differ from the preliminary results announced in this press release.

Ambarella assumes no obligation and does not intend to update the forward- looking statements made in this press release, except as required by law.

Non-GAAPFinancial Measures The company has provided in this release non- GAAPfinancial information, including non-GAAPgross margin, net income (loss), and earnings (losses) per share, as a supplement to the condensed consolidated financial statements, which are prepared in accordance with generally accepted accounting principles (“GAAP”). Management uses these non-GAAPfinancial measures internally in analyzing the company’s financial results to assess operational performance and liquidity. The company believes that both management and investors benefit from referring to these non-GAAPfinancial measures in assessing its performance and when planning, forecasting and analyzing future periods. Further, the company believes these non-GAAPfinancial measures are useful to investors because they allow for greater transparency with respect to key financial metrics that the company uses in making operating decisions and because the company believes that investors and analysts use them to help assess the health of its business and for comparison to other companies. Non- GAAPresults are presented for supplemental informational purposes only for understanding the company’s operating results. The non-GAAPinformation should not be considered a substitute for financial information presented in accordance with GAAP and may be different from non-GAAPmeasures used by other companies. With respect to its financial results for the second quarter of fiscal year 2027, the company has provided below reconciliations of its non-GAAPfinancial measures to its most directly comparable GAAP financial measures. With respect to the company’s expectations for the third quarter of fiscal year 2027, a reconciliation of non-GAAPgross margin and non-GAAPoperating expenses guidance to the closest corresponding GAAP measure is not available without unreasonable efforts on a forward-looking basis due to the high variability and low visibility with respect to the charges excluded from these non-GAAPmeasures. We expect the variability of the above charges to have a significant, and potentially unpredictable, impact on our future GAAP financial results. AMBARELLA, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except share and per share data) (unaudited)

The following tables present details of stock-based compensation, acquisition- related costs and development project termination credit, included in each functional line item in the condensed consolidated statements of operations above:

The difference between GAAP and non-GAAPgross margin was 1.6% and 1.6%, or $1.7 million and $1.5 million, for the three months ended July 31, 2026 and 2025, respectively. The difference between GAAP and non-GAAPgross margin was 1.6% and 1.8%, or $3.2 million and $3.2 million, for the six months ended July 31, 2026 and 2025, respectively. The differences were due to the effect of stock-based compensation and acquisition-related costs.

AMBARELLA, INC. RECONCILIATION OF GAAP TO NON-GAAPDILUTED EARNINGS (LOSSES) PER SHARE (in thousands, except share and per share data)

July 31, January 31, 2026 2026 ────────────────────────────────────────────────────────────────────────────── ASSETS Current assets: Cash and cash equivalents $ 101,850 $ 191,019 Marketable debt securities 170,482 121,552 Accounts receivable, net 37,440 39,180 Inventories 76,923 52,246 Restricted cash 442 442 Prepaid expenses and other current 6,885 5,836 assets Total current assets 394,022 410,275 Property and equipment, net 12,061 11,553 Intangible assets, net 56,672 58,046 Operating lease 10,923 12,118 right-of-use assets, net Goodwill 303,625 303,625 Other non-current assets 2,902 2,983 Total assets $ 780,205 $ 798,600 LIABILITIES AND SHAREHOLDERS’ EQUITY Current liabilities: Accounts payable 26,478 54,029 Accrued and other current liabilities 86,490 97,964 Operating lease liabilities, current 2,229 2,027 Income taxes payable 2,309 1,531 Deferred revenue, current 20,865 22,393 Total current liabilities 138,371 177,944 Operating lease liabilities, 10,413 11,408 non-current Other long-term liabilities 11,105 14,459 Total liabilities 159,889 203,811 Shareholders’ equity: Preference shares — — Ordinary shares 20 19 Additional paid-in capital 973,864 922,119 Accumulated other comprehensive income (864 ) 573 (loss) Accumulated deficit (352,704 ) (327,922 ) Total shareholders’ equity 620,316 594,789 Total liabilities and shareholders’ $ 780,205 $ 798,600 equity

Full text with the tables
Exhibit 99.1 Ambarella, Inc. Announces Second Quarter Fiscal Year 2027 Financial
Results September 3, 2026 —Santa Clara, Calif. – Ambarella, Inc. (NASDAQ: AMBA),
an edge AI semiconductor company, today announced second quarter fiscal 2027
financial results for the period ended July 31, 2026.
                                                                                
       Revenue for the second quarter of fiscal 2027 was $108.1 million, up     
       13.2% from $95.5 million in the                                          
  •    same period in fiscal 2026. For the six months ended July 31, 2026,      
       revenue was $208.5 million, up 14.9% from $181.4 million for the six     
       months ended July 31, 2025.                                              
                                                                                
                                                                                
       Gross margin under U.S. generally accepted accounting principles (GAAP)  
       for the second quarter of fiscal 2027 was                                
       57.7%, compared with 58.9% for the same period in fiscal 2026. For the   
       six months ended July 31, 2026, GAAP gross margin was 58.0%, compared    
  •    with 59.4% for the six months ended July 31, 2025.                       
 ────────────────────────────────────────────────────────────────────────────── 
                                                                                
                                                                                
       GAAP net loss for the second quarter of fiscal 2027 was $6.7 million,    
       or loss per diluted ordinary share of                                    
       $0.15, compared with a GAAP net loss of $20.0 million, or loss per       
       diluted ordinary share of $0.47, for the same period in fiscal 2026.     
  •    GAAP net loss for the six months ended July 31, 2026 was $24.8 million   
       or loss per diluted                                                      
       ordinary share of $0.57. This compares with GAAP net loss of $44.3       
       million, or loss per diluted ordinary share of $1.05, for the six        
       months ended July 31, 2025.                                              
                                                                                
Financial results on a non-GAAPbasis for the second quarter of fiscal 2027 are
as follows:
                                                                                
       Gross margin on a non-GAAP basis for the second quarter of fiscal 2027   
       was 59.3%, compared with 60.5% for the same period in fiscal 2026. For   
       the six months ended July 31, 2026, non-GAAP gross margin was 59.6%,     
  •    compared with 61.2% for the six months ended July 31, 2025.              
 ────────────────────────────────────────────────────────────────────────────── 
                                                                                
                                                                                
       Non-GAAP net income for the second quarter of fiscal 2027 was            
       $8.2 million, or earnings per diluted ordinary share of $0.18. This      
       compares with non-GAAP net income of $6.4 million, or earnings per       
       diluted ordinary share of $0.15, for the same period in fiscal           
  •    2026. Non-GAAP net income for the six months ended July 31, 2026 was     
       $13.3 million, or earnings per diluted ordinary share of $0.30. This     
       compares with                                                            
       non-GAAP net income of $9.5 million, or earnings per diluted ordinary    
       share of $0.22, for the six months ended July 31, 2025.                  
                                                                                
Based on information available as of today, Ambarella is offering the following
guidance for the third quarter of fiscal year 2027, ending October 31, 2026:
                                                                             
  •    Revenue is expected to be between $115.0 million and $124.0 million.  
                                                                             
                                                                             
  •    Gross margin on a non-GAAP basis is expected to be between 59.0% and  
       60.0%.                                                                
                                                                             
                                                                             
  •    Non-GAAP operating expenses are expected to be between $56.5 million  
       and $59.5 million.                                                    
                                                                             
Ambarella reports gross margin, net income (loss) and earnings (losses) per
share in accordance with GAAP
and, additionally, on a non-GAAP basis. Non-GAAP financial information excludes
the impact of stock-based compensation and acquisition-related costs adjusted
for the
associated tax impact, which includes the effect of any benefits or shortfalls
recognized. In addition, in our second quarter of fiscal 2027, we recognized a
one-time $9.0 million reduction in our GAAP
research and development expense on release of a deposit liability following the
termination of a development project. Given the nature of this credit and that
it is non-recurring, we excluded it from
operating expenses for the purpose of reporting non-GAAP financial results. A
reconciliation of the GAAP to non-GAAP gross margin, net income (loss) and
earnings
(losses) per share for the periods presented, as well as a description of the
items excluded from the non-GAAP calculations, is included in the financial
statements portion of this press release.

Total cash, cash equivalents and marketable debt securities on hand at the end
of the second quarter of fiscal 2027 was $272.3 million, compared with
$277.8 million at the end of the prior quarter and $261.2 million at the end of
the same quarter a year ago.

“Our edge AI revenue reached
record levels in Q2, with balanced sequential growth in Auto and IoT markets
with very strong growth from our 5nm CV75 and CV72 AI SoCs. We are making
significant progress with our strategic priorities to extend our market reach
with new higher
value products and the implementation of new go-to-market strategies. These
include the introduction of our first stand-alone AI Accelerator, X7, and the
execution of 7-year agreements to develop the indirect sales channel with both
Macnica, a leading global technical distributor, and CapGemini, a leading global
engineering and systems integration firm,” said Fermi Wang,
President & CEO. “These developments are contributing to an increase in our
5-year serviceable market (“SAM”) forecast for edge AI and Physical AI.”

Quarterly Conference Call

Ambarella plans to hold a
conference call at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time today with
Fermi Wang, President and Chief Executive Officer, and John Young, Chief
Financial Officer, to discuss the second quarter of fiscal year 2027 results. A
live and archived
webcast of the call will be available on Ambarella’s website at for up to 30
days after the call.

About Ambarella

With an installed base of more than 50 million AI SoC units, Ambarella’s
products are utilized in a wide variety of physical edge
AI applications, spanning edge endpoint and edge infrastructure use cases
including physical security, vehicle safety, telematics, autonomy, portable
video, aerial drones, and other emerging robotic applications. Building on this
footprint,
Ambarella offers a full-stack edge AI platform, from highly optimized silicon
and programmable software to AI agentic frameworks that coordinate perception,
decision-making and control across devices. Ambarella’s low-power systems-on-
chip (SoCs) integrate proprietary and highly efficient perception and deep
learning neural network AI
accelerators, enabling electronic systems to become more productive with partial
or complete levels of machine autonomy. For more information, please visit

“Safe harbor” statement under the Private Securities Litigation Reform Act of
1995

This press release contains forward-looking statements that are not historical
facts and often can be identified by terms such as “outlook,”
“projected,” “intends,” “will,” “estimates,” “anticipates,” “expects,”
“believes,” “could,” “should,” or similar expressions, including the
guidance for the third quarter of fiscal year 2027 ending October 31, 2026, and
the comments of our CEO relating to demand for edge AI solutions, our progress
with strategic priorities to extend our market reach, our ability to
successfully
build an indirect sales channel, the forecasted size of our serviceable market
(“SAM”), and our ability to successfully penetrate the edge AI and Physical AI
markets. The achievement or success of the matters covered by such
forward-looking statements involves risks, uncertainties and assumptions. Our
actual results could differ materially from those predicted or implied and
reported results should not be considered as an indication of our future
performance.

The risks and uncertainties referred to above include, but are not limited to,
global economic and political conditions; changes in government policies,
including possible trade tariffs and restrictions; revenue being generated from
new customers or design wins, neither of which is assured; the commercial
success of our customers’ products; our customers’ ability to manage their
inventory requirements; our growth strategy; our ability to anticipate future
market demands and future needs of our customers, particularly for AI inference
applications; our ability to introduce, and to generate revenue from, new and
enhanced
solutions; our ability to develop, and to generate revenue from, new advanced
technologies, such as AI functionality and advanced networks, including vision-
language models and GenAI; our ability to retain and expand customer
relationships and to
achieve design wins; the expansion of our current markets and our ability to
successfully enter new markets and applications, such as edge infrastructure;
anticipated trends and challenges, including competition, in the markets in
which we operate;
risks associated with global health conditions and associated risk mitigation
measures; our ability to effectively manage growth; our ability to retain key
employees; and the potential for intellectual property disputes or other
litigation.

Further information on these and other factors that could affect our financial
results is included in the company’s Annual Report on Form 10-K for our 2026
fiscal year, which is on file with the Securities and Exchange Commission.
Additional information will also be set forth in the company’s quarterly reports
on Form 10-Q, annual reports on Form 10-K and other filings the company makes
with the Securities and Exchange Commission from time to time, copies of which
may be obtained by
visiting the Investor Relations portion of our web site at or the SEC’s web site
at www.sec.gov. Undue reliance should not be placed on the forward-looking
statements in this release, which are based on information
available to us on the date hereof. The results we report in our Quarterly
Report on Form 10-Q for the second quarter of fiscal 2027 ended July 31, 2026
could differ from the preliminary results announced
in this press release.

Ambarella assumes no obligation and does not intend to update the forward-
looking statements made in this press release, except as
required by law.

Non-GAAPFinancial Measures The company has provided in this release non-
GAAPfinancial information, including non-GAAPgross margin, net income (loss),
and earnings (losses) per share, as a supplement to the condensed consolidated
financial statements, which are prepared in accordance with generally accepted
accounting principles (“GAAP”). Management uses these non-GAAPfinancial measures
internally in analyzing the company’s financial results to assess operational
performance and liquidity. The company believes that both management and
investors benefit from referring to these non-GAAPfinancial measures in
assessing its performance and when planning, forecasting and analyzing future
periods. Further, the company believes these non-GAAPfinancial measures are
useful to investors because they allow for greater transparency with respect to
key financial metrics that the company uses in making operating decisions and
because the company believes that investors and analysts use them to help assess
the health of its business and for comparison to other companies. Non-
GAAPresults are presented for supplemental informational purposes only for
understanding the company’s operating results. The non-GAAPinformation should
not be considered a substitute for financial information presented in accordance
with GAAP and may be different from non-GAAPmeasures used by other companies.
With respect to its financial results for the second quarter of fiscal year
2027, the company has provided below reconciliations of its non-GAAPfinancial
measures to its most directly comparable GAAP financial measures. With respect
to the company’s expectations for the third quarter of fiscal year 2027, a
reconciliation of non-GAAPgross margin and non-GAAPoperating expenses guidance
to the closest corresponding GAAP measure is not available without unreasonable
efforts on a forward-looking basis due to the high variability and low
visibility with respect to the charges excluded from these non-GAAPmeasures. We
expect the variability of the above charges to have a significant, and
potentially unpredictable, impact on our future GAAP financial results.
AMBARELLA, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands,
except share and per share data) (unaudited)
                                                                                
                Three                                 Six                       
                Mont…                               Mont…                       
                Ended                               Ended                       
                 July                                July                       
          2026    31,       2025              2026    31,       2025            
 ────────────────────────────────────────────────────────────────────────────── 
  Rev…    $     108,…       $     95,5…       $     208,…       $     181,…     
  Cost                                                                          
  of            45,7…             39,2…             87,4…             73,6…     
  rev…                                                                          
  Gro…          62,4…             56,2…             121,…             107,…     
  pro…                                                                          
  Ope…                                                                          
  exp…                                                                          
  Res…                                                                          
  and           50,5…             59,7…             108,…             118,…     
  dev…                                                                          
  Sel…                                                                          
  gen…          19,9…             18,4…             39,8…             37,0…     
  and                                                                           
  adm…                                                                          
  Tot…                                                                          
  ope…          70,5…             78,2…             148,…             155,…     
  exp…                                                                          
  Loss                                                                          
  from          (8,1…  )          (21,…  )          (27,…  )          (47,…  )  
  ope…                                                                          
  Oth…                                                                          
  inc…          1,806             2,247             3,889             4,422     
  net                                                                           
  Loss                                                                          
  bef…          (6,3…  )          (19,…  )          (23,…  )          (43,…  )  
  inc…                                                                          
  tax…                                                                          
  Pro…                                                                          
  for             352               253             1,112               898     
  inc…                                                                          
  tax…                                                                          
  Net     $     (6,6…  )    $     (19,…  )    $     (24,…  )    $     (44,…  )  
  loss                                                                          
  Net                                                                           
  loss                                                                          
  per                                                                           
  sha…                                                                          
  att…                                                                          
  to                                                                            
  ord…                                                                          
  sha…                                                                          
  Bas…    $     (0.15  )    $     (0.47  )    $     (0.57  )    $     (1.05  )  
  Dil…    $     (0.15  )    $     (0.47  )    $     (0.57  )    $     (1.05  )  
  Wei…                                                                          
  sha…                                                                          
  used                                                                          
  to                                                                            
  com…                                                                          
  net                                                                           
  loss                                                                          
  per                                                                           
  sha…                                                                          
  att…                                                                          
  to                                                                            
  ord…                                                                          
  sha…                                                                          
  Bas…          44,0…             42,5…             43,8…             42,3…     
  Dil…          44,0…             42,5…             43,8…             42,3…     
                                                                                
The following tables present details of stock-based compensation, acquisition-
related costs and development project termination credit, included in each
functional line item in the condensed consolidated statements of operations
above:
                                                                                
            Three                                                               
           Months                                                               
            Ended                                                               
             July                                Six                            
              31,                              Mont…                            
             2026                              Ended                            
           (unau…                               July                            
  Stoc…        in                                31,                            
  comp…    thous…              2025             2026               2025         
 ────────────────────────────────────────────────────────────────────────────── 
  Cost                                                                          
  of            $    951          $     780        $   1,734          $  1,731  
  reve…                                                                         
  Rese…                                                                         
  and              14,0…             16,972           27,721             34,5…  
  deve…                                                                         
  Sell…                                                                         
  gene…            7,742              7,436           15,138             15,0…  
  and                                                                           
  admi…                                                                         
  Total                                                                         
  stoc…         $  22,7…          $  25,188        $  44,593          $  51,3…  
  comp…                                                                         
            Three                                Six                            
           Months                              Mont…                            
            Ended                              Ended                            
             July                               July                            
              31,                                31,                            
             2026              2025             2026               2025         
           -unau…                                                               
               in                                                               
           thous…                                                               
  Acqu…                                                                         
  cost…                                                                         
  Cost                                                                          
  of            $    757          $     757        $   1,514          $  1,514  
  reve…                                                                         
  Rese…                                                                         
  and                  —                  —                —                 —  
  deve…                                                                         
  Sell…                                                                         
  gene…              456                456              912               912  
  and                                                                           
  admi…                                                                         
  Total                                                                         
  acqu…         $  1,213          $   1,213        $   2,426          $  2,426  
  costs                                                                         
            Three                                Six                            
           Months                              Mont…                            
            Ended                              Ended                            
             July                               July                            
              31,                                31,                            
             2026              2025             2026               2025         
           -unau…                                                               
               in                                                               
           thous…                                                               
  Deve…                                                                         
  proj…                                                                         
  term…                                                                         
  cred…                                                                         
  Cost                                                                          
  of            $      —          $       —        $       —          $      —  
  reve…                                                                         
  Rese…                                                                         
  and              (9,0…  )               —           (9,000  )              —  
  deve…                                                                         
  Sell…                                                                         
  gene…                —                  —                —                 —  
  and                                                                           
  admi…                                                                         
  Total                                                                         
  deve…                                                                         
  proj…         $  (9,0…  )       $       —        $  (9,000  )       $      —  
  term…                                                                         
  cred…                                                                         
                                                                                
The difference between GAAP and non-GAAPgross margin was 1.6% and 1.6%, or $1.7
million and $1.5 million, for the three months ended July 31, 2026 and 2025,
respectively. The difference between GAAP and non-GAAPgross margin was 1.6% and
1.8%, or $3.2 million and $3.2 million, for the six months ended July 31, 2026
and 2025, respectively. The differences were due to the effect of stock-based
compensation and acquisition-related costs.

AMBARELLA, INC. RECONCILIATION OF GAAP TO NON-GAAPDILUTED EARNINGS (LOSSES) PER
SHARE (in thousands, except share and per share data)
                                                                                
          Three                               Six                               
          Mont…                               Mont…                             
          Ended                               Ended                             
          July                                July                              
          31,               2025              31,                               
          2026              (una…             2026              2025            
 ────────────────────────────────────────────────────────────────────────────── 
  GAAP                                                                          
  net     $      (6,…  )    $      (19…  )    $      (24…  )    $     (44,…  )  
  loss                                                                          
  Non…                                                                          
  adj…                                                                          
  Sto…                                                                          
  com…           22,…              25,…              44,…             51,3…     
  exp…                                                                          
  Acq…           1,2…              1,2…              2,4…             2,426     
  cos…                                                                          
  Dev…                                                                          
  pro…           (9,…  )              —              (9,…  )              —     
  ter…                                                                          
  cre…                                                                          
  Inc…                                                                          
  tax               9                22                29                36     
  eff…                                                                          
  Non…                                                                          
  net     $      8,2…       $      6,4…       $      13,…       $     9,457     
  inc…                                                                          
  GAAP                                                                          
  -                                                                             
  dil…           44,…              42,…              43,…             42,3…     
  wei…                                                                          
  ave…                                                                          
  sha…                                                                          
  Non…                                                                          
  -                                                                             
  dil…           44,…              42,…              44,…             42,6…     
  wei…                                                                          
  ave…                                                                          
  sha…                                                                          
  GAAP                                                                          
  -                                                                             
  dil…                                                                          
  net     $      (0.…  )    $      (0.…  )    $      (0.…  )    $     (1.05  )  
  loss                                                                          
  per                                                                           
  sha…                                                                          
  Non…                                                                          
  adj…                                                                          
  Sto…                                                                          
  com…           0.52              0.59              1.02              1.21     
  exp…                                                                          
  Acq…           0.03              0.03              0.06              0.06     
  cos…                                                                          
  Dev…                                                                          
  pro…           (0.…  )              —              (0.…  )              —     
  ter…                                                                          
  cre…                                                                          
  Inc…                                                                          
  tax               —                 —                 —                 —     
  eff…                                                                          
  Eff…                                                                          
  of                                                                            
  Non…                                                                          
  -              (0.…  )              —                 —                 —     
  dil…                                                                          
  wei…                                                                          
  ave…                                                                          
  sha…                                                                          
  Non…                                                                          
  -                                                                             
  dil…                                                                          
  net     $      0.18       $      0.15       $      0.30       $      0.22     
  inc…                                                                          
  per                                                                           
  sha…                                                                          
                                                                                
AMBARELLA, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited, in thousands)
                                                                                
                                              July 31,          January 31,     
                                                  2026                 2026     
 ────────────────────────────────────────────────────────────────────────────── 
  ASSETS                                                                        
  Current assets:                                                               
  Cash and cash equivalents                $   101,850       $      191,019     
  Marketable debt securities                   170,482              121,552     
  Accounts receivable, net                      37,440               39,180     
  Inventories                                   76,923               52,246     
  Restricted cash                                  442                  442     
  Prepaid expenses and other current             6,885                5,836     
  assets                                                                        
  Total current assets                         394,022              410,275     
  Property and equipment, net                   12,061               11,553     
  Intangible assets, net                        56,672               58,046     
  Operating lease                               10,923               12,118     
  right-of-use assets, net                                                      
  Goodwill                                     303,625              303,625     
  Other non-current assets                       2,902                2,983     
  Total assets                             $   780,205       $      798,600     
  LIABILITIES AND SHAREHOLDERS’ EQUITY                                          
  Current liabilities:                                                          
  Accounts payable                              26,478               54,029     
  Accrued and other current liabilities         86,490               97,964     
  Operating lease liabilities, current           2,229                2,027     
  Income taxes payable                           2,309                1,531     
  Deferred revenue, current                     20,865               22,393     
  Total current liabilities                    138,371              177,944     
  Operating lease liabilities,                  10,413               11,408     
  non-current                                                                   
  Other long-term liabilities                   11,105               14,459     
  Total liabilities                            159,889              203,811     
  Shareholders’ equity:                                                         
  Preference shares                                  —                    —     
  Ordinary shares                                   20                   19     
  Additional paid-in capital                   973,864              922,119     
  Accumulated other comprehensive                                               
  income                                          (864  )               573     
  (loss)                                                                        
  Accumulated deficit                         (352,704  )          (327,922  )  
  Total shareholders’ equity                   620,316              594,789     
  Total liabilities and shareholders’      $   780,205       $      798,600     
  equity                                                                        
                                                                                
Contact: Louis Gerhardy 408.636.2310 [email protected]

Sources

The 8-K item 2.02 filings (SEC EDGAR) and their EX-99 exhibits: the results release and, when filed, prepared remarks or the call transcript.

Also

Said vs did: the targets in these releases against what was then reported. Filings: every filing.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/AMBA/export.csv") into a cell.

Next:Presentations
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.